Earli mission is to make cancer a benign experience.
Rather than rely on biomarkers that cancer may - or often may not - naturally provide, Earli's technology *forces* cancer cells to make a synthetic, non-human biomarker using gene therapy approaches. It's called a Synthetic Biopsy. It can then localize the cancer in a PET scanner.
Earli has been funded by Andreessen Horowitz's Bio Fund, Khosla, Perceptive Advisors, Casdin Capital, Sands Capital, Marc Benioff, Menlo Ventures, ZhenFund. Earli is based in the West Coast’s prime biotech hub in South San Francisco.
Company Details
Earli Inc. Questions
Earli Inc.'s website is earli.com
Earli Inc.'s LinkedIn profile is https://www.linkedin.com/company/earli
Earli Inc. has
38 employees.
View email and phone details for 38
employees at Earli Inc..
Earli Inc.'s industry is
Biotechnology Research
Earli Inc.'s top competitors are
Marin Biologic Laboratories,
Pattern Biosciences,
Nudge,
Tierra Biosciences,
Panacro,
Cellmax Life,
Evercrisp Biosciences,
Bitterroot Bio,
Gate Bioscience,
Karyon Bio.
Earli Inc.'s support email address is join@earli.com
Earli Inc.'s categories are Biotechnology Research
Earli Inc.'s founding year is 2018
